Inhibitory neurotransmitter receptors as therapeutic targets for chronic pain and anxiety disorders

抑制性神经递质受体作为慢性疼痛和焦虑症的治疗靶点

• 批准号: nhmrc : 1058542
• 负责人: Prof Joseph Lynch
• 金额: $ 50.9万
• 依托单位: The University of Queensland
• 依托单位国家: 澳大利亚
• 项目类别: Research Fellowships
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/inhibitory-neurotransmitter-receptors-anxiety-disorders/454683
• 关键词: Inhibitory; neurotransmitter; receptors; therapeutic; targets

There are currently few effective long-term treatments for chronic pain and anxiety disorders. Here we propose to develop innovative therapies for both of these debilitating neurological disorders. In addition, we plan to improve our current understanding of how these disorders occur in the first place. This may identify novel potential therapeutic strategies for treating pain, anxiety and a host of other neurological disorders.

目前对慢性疼痛和焦虑症的有效长期治疗方法很少。在这里，我们建议为这两种衰弱的神经系统疾病开发创新疗法。此外，我们计划提高我们目前对这些疾病是如何发生的理解。这可能为治疗疼痛、焦虑和许多其他神经系统疾病确定新的潜在治疗策略。